Revolutionizing Drug Discovery with NANOSTACKS™ Organ Models

Precision Organ Engineering for Targeted Drug Development

CellStacks_logo final.png__PID:7254133e-e70b-4817-9c70-05409c9a9693

Our Services

Enhance your drug discovery with our cutting-edge in-vitro human relevant models

liver icon.svg__PID:4d528045-83ed-40f6-81f6-e24c71426bd9

Hepatotoxicity and ADME services

brain model icons.png__PID:8195c4bd-2d6d-4dcd-a21a-721d2f2f8032

Neurotoxicity services

liver and brain connectedicon.png__PID:10e996fb-c3f4-4873-a73c-6caee6bc4431

Multiorgan toxicity services 

Our Technology 

CellStacks_logo final.png__PID:7254133e-e70b-4817-9c70-05409c9a9693

NANOSTACKS™ technology: advancing research through in-vivo relevant organ models

Explore the cutting edge of in-vitro modeling with NANOSTACKS™ technology, a meticulously designed platform offering validated models with in-vivo relevance. This innovation supports precise studies in drug discovery, disease modeling, and tissue engineering. Engage in a scientific exploration guided by the inherent precision and innovation of NANOSTACKS™ technology, providing valuable insights for diverse research applications.

TESTIMONIALS

"For biological research or drug discovery applications, striving towards organotypic structure and function will improve the translational relevance and predictivity of cell models. 3D assembly of multi-cellular structures, communication between cells within or across connected models alongside media flow are the focus of multiple organ on a chip (OOAC) technologies. NANOSTACKSTM is a new entry into the OOAC space. It has plate-based familiarity with the potential to develop and connect multiple cell models exploiting the multi-modular nature of the technology. Established cell or trans-well based models can be migrated into the format and connected in multiple combinations with or without media flow. The approach exploits existing laboratory equipment and requires minimal training, enabling a lower barrier to investment and reduced model transition to the format compared to other approaches on the market."

DR. MALCOLM HADDRICK

Lead Scientist at Medicines Discovery Catapult, UK

"NANOSTACKSTM is a true innovation for co-culture activities. The soluble factors including growth factors and cytokine can be smartly and conveniently introduced to targeted cellular population in a semi-quantitative manner. The working procedure is simple and easily implemented."

PROF. YING YANG

Professor in Biomaterials and Tissue Engineering at Keele University, UK

“NANOSTACKSTM is great technology and innovative technique. Very easy to use and instructions are well designed. This platform enables us to screen various compounds in-vitro during our research using nanoparticles, aptamers, and others. We are interested to better mimic skin barrier and blood brain barrier and are continuing to explore the use of NANOSTACKSTM for this purpose. Our research continues in this filed, to discover new products we would need models like NANOSTACKSTM for testing permeation and penetration of cell lines. I would recommend it and encourage other researchers to use it.”

DR. TAMARA ZWAIN

Lecturer in Pharmaceutics at University of Central Lancashire, UK

"NANOSTACKSTM can be used to overcome the serious limitations hampering the use of organotypic slice cultures in long-term experiments. The system allows sharing of cell secreted factors released from three or more types of cross-communicating cells/tissues and can be easily adapted in studying cell-cell interactions in complex organs like the salivary glands."

DR ABEER SHAALAN

Postdoctoral Research Associate at King's College London

The latest blogs

5 tips for making your own complex in vitro model

5 tips for making your own complex in vitro model

Discover 5 essential tips for designing and setting up a complex in vitro model (CIVM) that mimics the human body more effectively than traditional models. From maximizing cell types to validating your model, these insights will help you advance your research and increase its relevance

Read More
Human Organs-on-Chips: easier said than done

Human Organs-on-Chips: easier said than done

Discover the current state of the art in organ-on-a-chip technologies and how they compare to conventional cell culture methods. Dr. Valon Llabjani, Founder and CEO of Revivocell Limited, explores the advancements, limitations, and the need for improved models. Learn about Revivocell's CELLBLOKS® technology, a modular multi-organ/cell type co-culture system that bridges the gap between traditional methods and organs-on-a-chip approaches.

Read More

Need some help?

If you're interested in discovering how  our organ models can benefit your research, we invite you to get in touch with us. Our team is available to provide further insights and address any inquiries you may have.

Contact information

UK

Daresbury Laboratory, Sci-Tech Daresbury, Keckwick Lane Daresbury, Cheshire, WA4 4AD

+447588015987

info@revivocell.com

USA

BioLabs@NYU LANGONE, 180 Varick St, Floor 6, New York, NY 10014


info@revivocell.com

Revivocell Brands

NANOSTACKS stip white.png__PID:23bff30e-eca7-4125-9868-6ac89c7cf352
CellBloks_logo.ai registered trademark. white png.png__PID:71578730-e4eb-4f50-852a-7c721b84f60e